SCHEMBL19852400

SCHEMBL19852400

C=C(N)c1ccc(OC2CCNCC2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 3/20 0.56
PARP10 Q53GL7 1/20 0.50
CHEK2 O96017 1/20 0.49
FURIN P09958 1/20 0.44
ROCK1 Q13464 2/20 0.43
IKBKB O14920 1/20 0.42
SENP8 Q96LD8 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
HRH3 Q9Y5N1 2/20 0.41
ROCK2 O75116 1/20 0.40
PRKACA P17612 1/20 0.40
PRKCD Q05655 1/20 0.40
PRKG1 Q13976 1/20 0.40
PKN1 Q16512 1/20 0.40
PKN2 Q16513 1/20 0.40
AAK1 Q2M2I8 1/20 0.40
CDC42BPA Q5VT25 1/20 0.40
Q6ZSR9 Q6ZSR9 1/20 0.40
BMP2K Q9NSY1 1/20 0.40
CDC42BPB Q9Y5S2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4798997 0.83 PARP10 (0.73) HRH1PARP10CHEK2FURINSENP8
SCHEMBL15088391 0.83 HRH1 (0.56) HRH1PARP10CHEK2ROCK1IKBKB
Hydrochloric Acid SCHEMBL3636392 0.82 PARP10 (0.71) HRH1PARP10CHEK2SENP8SENP6
SCHEMBL19852401 0.81 HRH1 (0.53) HRH1PARP10CHEK2ROCK1IKBKB
SCHEMBL6121373 0.78 HRH1 (0.68) HRH1PARP10CHEK2ROCK1IKBKB
SCHEMBL4241025 0.78 HRH1 (0.62) HRH1PARP10CHEK2SENP8SENP6
Hydrochloric Acid SCHEMBL3636395 0.77 HRH1 (0.66) HRH1PARP10CHEK2ROCK1IKBKB
SCHEMBL8798736 0.77 HRH1 (0.66) HRH1PARP10CHEK2ROCK1IKBKB
SCHEMBL10964232 0.77 HRH1 (0.56) HRH1PARP10CHEK2ROCK1IKBKB
SCHEMBL13072384 0.77 HRH1 (0.56) HRH1PARP10CHEK2ROCK1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018026371-A1 DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS SUNOVION PHARMACEUTICALS INC. (US) 2018-02-08 WO disclosed